• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非图盖拉弗利的耐多药结核病和 HIV 患者的胸部 X 光发现和培养转换时间。

Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.

机构信息

Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, New York, United States of America.

出版信息

PLoS One. 2013 Sep 6;8(9):e73975. doi: 10.1371/journal.pone.0073975. eCollection 2013.

DOI:10.1371/journal.pone.0073975
PMID:24040132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3765317/
Abstract

BACKGROUND

The majority of patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are co-infected with HIV, but the radiographic features of MDR-TB and their relationship with time to sputum culture conversion in the antiretroviral therapy era have not been described.

METHODS

We reviewed baseline chest radiographs for 56 patients with MDR-TB from a rural area of South Africa. We analyzed the association of cavities, consolidation, pleural effusion and hilar lymphadenopathy with time to sputum culture conversion, adjusting for HIV status, baseline sputum smear and CD4 count.

RESULTS

Of the 56 subjects, 49 (88%) were HIV-positive, with a median CD4 count of 136 cells/mm(3) (IQR 65-249). Thirty-two (57%) patients were sputum smear positive. Twenty-two (39%) patients had a cavity and 37 (66%) patients had consolidations. Cavitary disease and consolidations were each associated with longer time to culture conversion on bivariate analysis but not after adjusting for sputum smear status (aORs 1.79 [0.94-3.42] and 1.09 [0.67-1.78], respectively). Positive baseline sputum smear remained independently associated with longer time to conversion (aOR 3.45 [1.39-8.59]). We found no association between pleural effusion or hilar lymphadenopathy and time to conversion. Seventy-nine percent of patients were cured at the end of treatment.

CONCLUSIONS

Despite high rates of HIV co-infection and advanced immunodeficiency, the majority of patients had severe pathology on baseline chest radiograph. Nevertheless, culture conversion rates were high and treatment outcomes were favorable. Cavitation and consolidation do not appear to have an independent association with time to culture conversion beyond that of baseline sputum smear status.

摘要

背景

南非大多数耐多药结核病(MDR-TB)患者合并感染 HIV,但在抗逆转录病毒治疗时代,MDR-TB 的放射学特征及其与痰培养转阴时间的关系尚未被描述。

方法

我们回顾了南非农村地区 56 例 MDR-TB 患者的基线胸片。我们分析了空洞、实变、胸腔积液和肺门淋巴结肿大与痰培养转阴时间的关系,调整了 HIV 状态、基线痰涂片和 CD4 计数。

结果

56 名受试者中,49 名(88%)为 HIV 阳性,CD4 计数中位数为 136 个细胞/mm³(IQR 65-249)。32 名(57%)患者痰涂片阳性。22 名(39%)患者有空洞,37 名(66%)患者有实变。空洞病变和实变在单变量分析中与培养转换时间较长相关,但在调整痰涂片状态后则无相关性(比值比 1.79 [0.94-3.42]和 1.09 [0.67-1.78])。阳性基线痰涂片仍与转换时间延长独立相关(比值比 3.45 [1.39-8.59])。我们未发现胸腔积液或肺门淋巴结肿大与转换时间之间存在关联。79%的患者在治疗结束时治愈。

结论

尽管 HIV 合并感染率高且免疫缺陷严重,但大多数患者在基线胸片上有严重的病理学表现。尽管如此,培养转化率高,治疗结局良好。空洞和实变与痰培养转阴时间的关系似乎并不独立于基线痰涂片状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db0/3765317/c1a960338dc2/pone.0073975.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db0/3765317/c1a960338dc2/pone.0073975.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db0/3765317/c1a960338dc2/pone.0073975.g001.jpg

相似文献

1
Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.南非图盖拉弗利的耐多药结核病和 HIV 患者的胸部 X 光发现和培养转换时间。
PLoS One. 2013 Sep 6;8(9):e73975. doi: 10.1371/journal.pone.0073975. eCollection 2013.
2
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.南非图盖拉弗利的 HIV 合并耐多药结核病患者的文化转变。
PLoS One. 2011 Jan 6;6(1):e15841. doi: 10.1371/journal.pone.0015841.
3
Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.博茨瓦纳人类免疫缺陷病毒对早期耐多药结核病治疗结局的影响。
Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.
4
Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.南非耐多药结核病-人类免疫缺陷病毒合并感染患者的同步治疗可提高生存率和治愈率。
Clin Infect Dis. 2018 Apr 3;66(8):1246-1253. doi: 10.1093/cid/cix1125.
5
Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.时间到痰涂片和培养转换耐多药结核在贡德尔大学医院,埃塞俄比亚西北部。
PLoS One. 2018 Jun 26;13(6):e0198080. doi: 10.1371/journal.pone.0198080. eCollection 2018.
6
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.耐多药结核病痰培养转阴时间:预测因素及其与治疗结果的关系
Ann Intern Med. 2006 May 2;144(9):650-9. doi: 10.7326/0003-4819-144-9-200605020-00008.
7
Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.南非约翰内斯堡一家初级保健诊所采用单点即时检测 xpert MTB/RIF 对疑似结核病患者进行筛查,其治疗时间与患者结局。
PLoS One. 2013 Jun 6;8(6):e65421. doi: 10.1371/journal.pone.0065421. Print 2013.
8
Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.维生素D受体基因多态性与南非耐多药结核病患者痰培养转阴率降低有关。
PLoS One. 2017 Jul 10;12(7):e0180916. doi: 10.1371/journal.pone.0180916. eCollection 2017.
9
Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.埃塞俄比亚亚的斯亚贝巴警报综合专科医院耐多药结核病患者痰培养转化时间的决定因素:一项回顾性队列研究。
PLoS One. 2024 May 31;19(5):e0304507. doi: 10.1371/journal.pone.0304507. eCollection 2024.
10
Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples.通过对南非 HIV 感染者的痰液样本进行主动监测,发现了相当比例的耐多药结核病。
Clin Infect Dis. 2010 Apr 1;50(7):1053-9. doi: 10.1086/651119.

引用本文的文献

1
Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen.STREET 阶段 1 试验中利福平耐药结核病的放射学特征及其对短程方案中培养物转换时间的影响。
BMC Infect Dis. 2024 Jan 30;24(1):144. doi: 10.1186/s12879-024-09039-z.
2
Sputum smear conversion and treatment outcomes among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia: A 9-years data analysis.埃塞俄比亚东部耐药肺结核患者的痰涂片转阴情况及治疗结果:9年数据分析
Front Med (Lausanne). 2022 Dec 1;9:1007757. doi: 10.3389/fmed.2022.1007757. eCollection 2022.
3

本文引用的文献

1
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.南非一家农村医院的耐多药结核病的医院内传播。
J Infect Dis. 2013 Jan 1;207(1):9-17. doi: 10.1093/infdis/jis631. Epub 2012 Nov 19.
2
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.南非农村地区耐多药结核病和艾滋病的综合家庭治疗:一种替代护理模式。
Int J Tuberc Lung Dis. 2012 Aug;16(8):998-1004. doi: 10.5588/ijtld.11.0713. Epub 2012 Jun 5.
3
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study.
耐多药结核病患者药物不良反应的发生率及管理:一项前瞻性研究的分析
Front Pharmacol. 2022 Jun 2;13:883483. doi: 10.3389/fphar.2022.883483. eCollection 2022.
4
Chest X-ray findings in drug-sensitive and drug-resistant pulmonary tuberculosis patients in Uganda.乌干达药物敏感和耐药肺结核患者的胸部X光检查结果
J Clin Tuberc Other Mycobact Dis. 2022 Mar 25;27:100312. doi: 10.1016/j.jctube.2022.100312. eCollection 2022 May.
5
Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study.在埃塞俄比亚接受多药耐药结核病治疗的患者强化期治疗结果及其相关因素:一项回顾性队列研究。
BMC Infect Dis. 2019 Sep 18;19(1):818. doi: 10.1186/s12879-019-4411-7.
6
Comparison of chest X-ray lesion characteristics of multidrug-resistant tuberculosis and non-tuberculous mycobacterial infection.耐多药结核病与非结核分枝杆菌感染的胸部X线病变特征比较。
Pol J Radiol. 2019 Mar 23;84:e162-e170. doi: 10.5114/pjr.2019.84515. eCollection 2019.
7
Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania.坦桑尼亚耐多药结核病患者治疗结果的预测因素
Tuberc Res Treat. 2019 Feb 12;2019:3569018. doi: 10.1155/2019/3569018. eCollection 2019.
8
Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.时间到痰培养转换及其决定因素在耐多药结核病患者在公立医疗机构的阿姆哈拉州:一个多中心回顾性随访研究。
PLoS One. 2018 Jun 21;13(6):e0199320. doi: 10.1371/journal.pone.0199320. eCollection 2018.
9
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis.初治涂阳肺结核患者胸片严重程度与细菌负荷的关系。
BMC Med. 2018 May 21;16(1):73. doi: 10.1186/s12916-018-1053-3.
10
Clinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, Brazil.耐多药和敏感结核病患者的临床特征及治疗结果:巴西阿雷格里港的一项历史性队列研究
PLoS One. 2016 Aug 9;11(8):e0160109. doi: 10.1371/journal.pone.0160109. eCollection 2016.
高 HIV 流行地区耐多药和广泛耐药结核病患者死亡的危险因素。
Int J Tuberc Lung Dis. 2012 Jan;16(1):90-7. doi: 10.5588/ijtld.11.0153.
4
Pretreatment and posttreatment radiography in patients with pulmonary tuberculosis with and without human immunodeficiency virus infection.肺结核合并和不合并人类免疫缺陷病毒感染患者的治疗前后影像学检查。
Jpn J Radiol. 2011 Oct;29(8):554-62. doi: 10.1007/s11604-011-0597-3. Epub 2011 Sep 17.
5
Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.液体培养基中转阳时间的地域差异:结核病临床试验联盟研究 28 号。非洲的培养转阳时间延迟。
PLoS One. 2011 Apr 11;6(4):e18358. doi: 10.1371/journal.pone.0018358.
6
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.南非图盖拉弗利的 HIV 合并耐多药结核病患者的文化转变。
PLoS One. 2011 Jan 6;6(1):e15841. doi: 10.1371/journal.pone.0015841.
7
Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection.人类免疫缺陷病毒与结核病合并感染疫情的新动态。
Am J Respir Crit Care Med. 2011 Apr 15;183(8):987-97. doi: 10.1164/rccm.201008-1246CI. Epub 2010 Dec 22.
8
HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.HIV 合并感染多重和广泛耐药结核病会导致早期高死亡率。
Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6. doi: 10.1164/rccm.200907-0989OC. Epub 2009 Oct 15.
9
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.在肺结核强化期治疗中用莫西沙星替代异烟肼。
Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30.
10
Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.耐多药和广泛耐药肺结核治疗效果不佳的预测因素。
Eur Respir J. 2009 May;33(5):1085-94. doi: 10.1183/09031936.00155708. Epub 2009 Jan 22.